Patents for C07C 233 - Carboxylic acid amides (28,881) |
---|
04/12/2006 | EP1643986A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer s disease |
04/12/2006 | EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
04/12/2006 | EP1005356B1 Novel antibacterial agents |
04/12/2006 | CN1759099A Substituted aniline derivatives |
04/12/2006 | CN1759096A Method for the purification of dimethylacetamide (DMAc) |
04/12/2006 | CN1759095A N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
04/12/2006 | CN1759093A Azide free process for preparing 1,2-diamino compounds |
04/12/2006 | CN1758925A Methods of radiofluorination of biologically active vectors |
04/12/2006 | CN1250519C Amine derivative with K channel regulation function and its preparing process and application |
04/12/2006 | CN1250518C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application |
04/12/2006 | CN1250207C 4, 4-diaryl butadienes compound and use of ultraviolet-ray filtering agent |
04/11/2006 | US7026522 Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols |
04/11/2006 | US7026514 Compounds used to treat alcoholism |
04/11/2006 | US7026511 Synthesis of N-vinylformamide |
04/11/2006 | US7026510 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
04/11/2006 | US7026501 Inhibitors of α4 mediated cell adhesion |
04/11/2006 | US7026498 Coordination catalyst containing ligand |
04/11/2006 | US7026419 Adhesives and sealants |
04/11/2006 | CA2229470C Process for the purification of an intermediate in the preparation of iopamidol |
04/11/2006 | CA2217030C Protease inhibiting succinic acid derivatives |
04/11/2006 | CA2198383C Benzene compound and pharmaceutical use thereof |
04/11/2006 | CA2155013C C2 taxane derivatives and pharmaceutical compositions containing them |
04/06/2006 | WO2006026747A3 Diphenylethylene compounds and uses thereof |
04/06/2006 | US20060074111 Chemical compounds |
04/06/2006 | US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
04/05/2006 | EP1642886A2 Saturated and unsaturated N-Alkamides exhibiting taste and flavor enhancement effect in flavor compositions |
04/05/2006 | EP1641759A2 Malonamide derivatives |
04/05/2006 | EP1641748A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease |
04/05/2006 | EP1641744A2 Crystalline form of b2 adrenergic receptor agonist |
04/05/2006 | EP1641740A1 Method for producing an optically active nitro compound |
04/05/2006 | EP1641559A1 A silver-catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition for the epoxidation of ethylene |
04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
04/05/2006 | EP0933993B1 Substituted cyclopentane compounds useful as neuraminidase inhibitors |
04/05/2006 | EP0897747B1 Nitration or carboxylation catalysts |
04/05/2006 | CN1754899A Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds |
04/05/2006 | CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
04/05/2006 | CN1249210C Asymmetrical imide bleaching activators and compositions employing the same |
04/05/2006 | CN1249020C Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
04/05/2006 | CN1249019C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
04/04/2006 | US7022879 Phase change ink formulations, colorant formulations, and methods of forming colorants |
04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
04/04/2006 | CA2258764C Inhibitors of oleamide hydrolase |
03/30/2006 | WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
03/30/2006 | WO2006033000A2 N-ethyl hydroxyethylamine useful in treating cns conditions |
03/30/2006 | WO2006032999A1 N-methyl hydroxyethylamine useful in treating cns conditions |
03/30/2006 | WO2006032893A2 Trityl derivatives for enhancing mass spectrometry |
03/30/2006 | US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
03/30/2006 | CA2581023A1 N-methyl hydroxyethylamine useful in treating cns conditions |
03/30/2006 | CA2580775A1 N-ethyl hydroxyethylamine useful in treating cns conditions |
03/30/2006 | CA2580238A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
03/29/2006 | EP1640359A2 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides |
03/29/2006 | CN1247529C Process for preparing N-aroyl-L-glutaminic acid |
03/29/2006 | CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
03/29/2006 | CN1247526C Diaminodicarboxylic acid and its intermediate |
03/29/2006 | CN1247511C Tropolone derivative |
03/28/2006 | US7019094 Intermediate products, methods for their preparation and use thereof |
03/28/2006 | US7019020 2-benzoxazolyl benzene derivatives and their use as UV screening agents |
03/28/2006 | US7018850 Luminescent lanthanide metal chelate for use as tool in diagnostic analysis |
03/28/2006 | US7018610 Poly-L-R-Y, where poly represents a polymer( such as polystyrene homo or copolymer) R= aryl or heteroaryl, L= R3-Sn-R3 (R3= alkyl, alenyl or alkynyl), Y= hydrogen, alkyl, alkoxy, carbonyl, formyl, amido, amino, carobxyamido etc. |
03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
03/28/2006 | CA2386793C New selective retinoid agonists |
03/28/2006 | CA2244862C Substituted amide derivatives |
03/28/2006 | CA2153805C C10 taxane derivatives and pharmaceutical compositions |
03/23/2006 | WO2006030892A1 Process for production of heterocyclic compounds |
03/23/2006 | WO2006029799A1 Iodine-phenyl-substituted cyclic cetoenols |
03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
03/23/2006 | US20060062751 Novel surfactants and use thereof |
03/23/2006 | US20060062726 with iodophenyl group (radioisotope), as a membrane component of liposomes, which enables lesion-selective contrast X-ray radiography of a vascular disease; metabolized in the liver, not accumulated in living bodies |
03/23/2006 | DE10297824T5 Verfahren zum Einsatz von Wasserstoff zur reduktiven Acylierung von Nitro-, Azido- und Cyanarenen A method of using hydrogen for the reductive acylation of nitro, azido and cyano arenes |
03/23/2006 | CA2580328A1 Iodine-phenyl-substituted cyclic ketoenols |
03/23/2006 | CA2580131A1 Substituted aniline derivatives |
03/22/2006 | EP1636191A2 Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
03/22/2006 | EP1636168A1 Method for continuously producing alkylamino(meth)acrylamides |
03/22/2006 | CN1751020A Process for the preparation of N-substituted formamides |
03/22/2006 | CN1751018A 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
03/22/2006 | CN1750839A Administration of capsaicinoids |
03/22/2006 | CN1749238A Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions |
03/22/2006 | CN1246300C Resorcinol derivatives |
03/22/2006 | CN1246296C Process for preparing 2-ethyl-N-(ethoxy methyl)-alpha-chloroacetanilide |
03/22/2006 | CN1246287C Binaphthol derivative and method for producing same |
03/22/2006 | CN1245936C Detergent composition containing new glycine derivative and its use |
03/21/2006 | US7015342 Enantiomerically enriched bidentate organophosphorus ferrocenyl ligands which are particularly useful for enantioselective hydrogenation |
03/21/2006 | US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
03/21/2006 | CA2245647C Novel bridged cyclic amino acids as pharmaceutical agents |
03/21/2006 | CA2147854C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
03/16/2006 | WO2006029135A1 Improved process for the synthesis of indanylamine or aminotetralin derivatives and novel intermediates |
03/16/2006 | WO2006027252A1 Sigma receptor ligands |
03/16/2006 | WO2006026875A1 Anti-bacterial compounds |
03/16/2006 | US20060058396 Amide compounds for the potentiation of cholinergic activity |
03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
03/16/2006 | US20060057194 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy |
03/16/2006 | DE102004037445A1 New indolizine and azaindolizine carboxamide derivatives, useful for treating e.g. schizophrenia and urinary incontinence, are ligands for serotinergic receptors |
03/16/2006 | DE102004035978A1 New aminoadamantane derivatives useful for treating e.g. viral diseases, Parkinson's disease, Huntington's chorea, Alzheimer's disease, autism, tinnitus, Tourette syndrome, hypertension, sleep disorders and psychosis |
03/16/2006 | CA2591321A1 Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase |
03/16/2006 | CA2577610A1 Sigma receptor ligands |
03/15/2006 | EP1633762A1 Ligands |
03/15/2006 | EP1633721A1 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives |